Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
85 hedge funds and large institutions have $522M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 11 closing their positions.
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
6% more funds holding
Funds holding: 80 → 85 (+5)
0% more capital invested
Capital invested by funds: $522M → $522M (+$40.5K)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
96% less call options, than puts
Call options by funds: $778K | Put options by funds: $20.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$13.9M |
| 2 |
BlackRock
New York
|
+$7.3M |
| 3 |
Millennium Management
New York
|
+$4.84M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.78M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$3.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$11.6M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$7.49M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$5.02M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.48M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.67M |
DCPH Hedge Fund Activity: Q2 2019 in Review
85 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q2 2019, worth a combined $522M — up 0.01% from $522M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new DCPH positions and 11 closed out — a net gain of 7 holders — while 36 added to existing stakes and 17 trimmed.
The largest buyer was Redmile Group, adding an estimated $13.9M. The largest seller was AllianceBernstein, cutting an estimated $11.6M.
- 85 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q2 2019, up from 80 in Q1 2019.
- Funds reported $522M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q2 2019, up 0.01% quarter-over-quarter.
- 18 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q2 2019 and 11 closed out, a net change of +7 holders.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q2 2019 was Redmile Group, an estimated $13.9M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q2 2019 was AllianceBernstein, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2019.